Navigation Links
Vestiage Signs Buyside Engagement Agreement with CJK Securities

Newport Beach, California (PRWEB) April 29, 2013

Vestiage Inc, a publicly traded anti-aging lifestyle company focused on science-based, highly effective premium branded cosmeceuticals and nutraceuticals, announced today that it has signed a buyside agreement with CJK Securities to accelerate the Company's Acquisition Initiative.

"I have known CJK for some time now and they have a fantastic ability to know what we're looking for and to find assets that nobody else knows about that fit our Acquisition Initiative and our niche well", said Scott Kimball, CEO of Vestiage. "They also know our philosophy and Vestiage well. They are highly responsive and professional. Working with them has always been easy and a pleasure for us."

For more information on the Vestiage Acquisition Initiative, please visit the Company website.

About Vestiage
Vestiage is a leading publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean based and patented botanically-based ingredients and science to produce potent and effective products using clinically proven ingredients. Using high potency and novel ingredient combinations allows Vestiage to offer highly effective cosmeceuticals such as Reluma, and multifunctional nutraceuticals through Monterey Bay Nutraceuticals. Vestiage brands address the top “in demand” anti-aging consumer concerns. To learn more, visit the Company website.

About CJK Securities
CJK Securities, Inc. is a licensed broker-dealer member of FINRA that provides financial advisory services to Middle Market companies whether owned by a family, several investors, or by a venture capital or private equity firm. During their careers, the CJK team has completed over $2 billion of sell-side, buy-side and capital formation transactions. CJK provides focused, personalized and responsive service while working closely with our clients' personnel to bring transactions to a successful close. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage Announces Key Partners for Launch of Monterey Bay Nutraceuticals Anti-Aging Wellness Products
2. Vestiage Announces Filing of Disclosure Statement with Exchange
3. Vestiage CEO Comments on Immortal Life
4. Vestiage to Partner with Skincare By Alana
5. Vertilon Signs Crisel Instruments as its Distributor in Italy
6. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
7. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
8. Samsung Thales signs Development Agreement with Novelda
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. Algae.Tec Signs MOU with WorleyParsons for Global Project Development Program
11. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... JOLLA, Calif. , Oct. 29, 2015  The ... a new report titled, "DNA Synthesis and Biosecurity: Lessons ... well the Department of Health and Human Services guidance ... issued in 2010. --> ... but it also has the potential to pose unique ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):